Prognostic differences of catestatin among young and elderly patients with acute myocardial infarction

Wei-xian Xu, Yuan-yuan Fan, Yao Song, Xin Liu, Hui Liu, Li-jun Guo

Table 1. The differences of baseline clinical characteristics between MACE and non-MACE group respectively among young and elderly patients

Variables Young patients (<60 years old) Elderly patients (≥60 years old) Non-MACE (n=93) MACE (n=9) P Non-MACE (n=48) MACE (n=15) P Male 79 (84.9) 7 (77.8) 0.572 28 (58.3) 11 (73.3) 0.296 Hypertension 54 (58.1) 7 (77.8) 0.249 41 (85.4) 9 (60.0) 0.034 Dyslipidemia 57 (61.3) 5 (55.6) 0.737 26 (54.2) 10 (66.7) 0.393 DM 27 (29.0) 3 (33.3) 0.787 15 (31.3) 3 (20.2) 0.400 Smoke 62 (66.7) 6 (66.7) 0.990 23 (47.9) 9 (60.0) 0.330 BMI, kg/m2 26.4±2.6 26.1±3.4 0.802 25.8±3.9 27.1±2.8 0.346 Age, years old 45.4±7.1 46.2±5.8 0.745 68.1±6.5 66.7±6.3 0.484 WBC, ×109/L 8.73±3.32 9.52±2.93 0.517 6.72±2.69 8.07±2.88 0.149 HB, g/L 145.45±13.74 131.63±17.33 0.009* 130.61±14.07 161.00±74.46 0.017* PLT, ×109/L 217.76±47.02 210.75±77.17 0.707 182.24±70.31 205.31±57.50 0.307 UA, μmol/L 366.24±171.85 325.38±96.28 0.511 340.19±89.81 356.21±67.89 0.550 TCHO, mmol/L 4.66±1.17 4.76±0.98 0.800 4.33±0.96 4.77±0.88 0.146 TG, mmol/L 2.29±1.44 2.12±1.02 0.733 1.90±2.15 2.08±0.96 0.762 HDL-C, mmol/L 0.93±0.21 0.93±0.18 0.997 1.04±0.25 0.94±0.28 0.203 LDL-C, mmol/L 2.95±1.12 2.96±0.86 0.964 2.53±0.72 2.96±0.62 0.050 GLU, mmol/L 5.97±2.42 6.31±2.67 0.702 5.20±0.83 5.82±2.44 0.238 HBA1C, % 6.52±1.46 7.13±1.96 0.342 6.38±1.22 6.24±1.02 0.768 LVEF, % 64.56±10.58 53.67±10.27 0.004* 65.44±11.29 62.33±11.15 0.358 Cr, μmol/L 86.21±18.80 76.56±17.40 0.142 84.94±15.92 92.67±21.04 0.135 CK-MB, U/L 58.52±19.67 153.25±75.63 0.014* 56.28±19.52 50.85±14.66 0.879 NT-proBNP, pg/mL 890.36±117.88 1309.29±440.22 0.552 1302.17±511.18 513.70±325.02 0.642 Catestatin, ng/mL 0.98±0.78 0.69±0.49 0.275 1.31±0.77 0.76±0.50 0.012*